Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-21-022540

Director bought 3,712 shares at $5.30 ($19,674)

From the SEC's structured data for this filing

Trades in this filing

Peyer James · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-27 Purchase : show line 1 in the form +3,712 $5.30 $19,674 4,837,998 I
Open-market purchases · 3,712 sh · avg $5.30 · $19,674
Loading xslF345X03/doc1.xml…